Live Breaking News & Updates on Nasrat hakim

Stay informed with the latest breaking news from Nasrat hakim on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nasrat hakim and stay connected to the pulse of your community

Elite Pharmaceuticals, Inc. (PNK:ELTP) Q2 2024 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to Elite Pharmaceuticals Conference Call. At this time all lines have been placed on a listen-only moder.

Nasrat-hakim , Pharmaceuticals-inc , Pharmaceuticals-conference-call , Elite-pharmaceuticals , Call-transcript-november , Elite-pharmaceuticals-conference , Federal-securities-laws , Investor-relations , Chief-executive-officer , Boomerang-ward , Carter-ward

Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial ...

Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial ...

Nasrat-hakim , Biologics-inc , Exchange-commission , Amide-pharmaceutical-inc , Actavis-group , Enveric-biosciences-inc , Long-island-university-in-brooklyn , Pharmaceuticals-inc-dianne , Centennial-communications-corp , News-network , Pharmaceuticals-inc , Elite-pharmaceuticals

Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer

Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
stlouisstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stlouisstar.com Daily Mail and Mail on Sunday newspapers.

Nasrat-hakim , Pharmaceuticals-inc , Long-island-university-in-brooklyn , Centennial-communications-corp , Enveric-biosciences-inc , Amide-pharmaceutical-inc , Actavis-group , Exchange-commission , Biologics-inc , Elite-pharmaceuticals , Carter-ward , Chief-financial-officer

Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer

NORTHVALE, NJ / ACCESSWIRE / May 3, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, today

Barbera , Nasrat-hakim , Mark-pellegrino , Digital-products-inc , Romaco-inc , Pharmaceuticals-inc , Kedrion-biopharma-inc , Exchange-commission , Pharmaceuticals-inc-view , Montclair-state-college , Elite-pharmaceuticals , Chief-financial-officer

Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial ...

Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial ...

Mark-pellegrino , Barbera , Nasrat-hakim , Exchange-commission , Digital-products-inc , News-network , Romaco-inc , Kedrion-biopharma-inc , Pharmaceuticals-inc , Montclair-state-college , Elite-pharmaceuticals , Chief-financial-officer

Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2022 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2022 Earnings Conference Call June 30, 2022, 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Robert Chen - Chief Financial...

United-states , Florida , China , California , India , Israel , America , Israeli , Chinese , Sungen-praxgen , Praxgen-sungen , Marc-bregman

Elite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial Officer

Elite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial Officer
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

Marc-bregman , Robert-chen , Nasrat-hakim , Medimetriks-pharmaceuticals , Lannett-company , University-of-southern-mississippi , Bradley-pharmaceuticals , Novartis , Exchange-commission , Business-administration , Pharmaceuticals-inc , Glenmark-pharmaceuticals-inc

Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules

(1)
NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has launched Elite's generic Loxapine capsules.
Elite entered a license, supply, and distribution agreement ("Agreement") with Prasco for Elite's Abbreviated New Drug Application (ANDA) for Loxapine Succinate capsules, 5 mg, 10 mg, 25 mg, and 50 mg ("Loxapine Capsules"). Loxapine is indicated for the treatment of schizophrenia and is currently listed on the FDA drug shortage list.
Prasco will be the exclusive U.S. distributor for Loxapine capsules, which will be marketed under Burel Pharmaceutical's label. Under the Agreement, Prasco will provide sales, marketing, and distribution for the product, and Elite will manufacture the product.

Ohio , United-states , Nasrat-hakim , Chris-arington , Exchange-commission , Lannett-company , Pharmaceuticals-inc , Glenmark-pharmaceuticals-inc , Elite-pharmaceuticals , Abbreviated-new-drug-application , Loxapine-succinate , Burel-pharmaceutical

Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules

Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules
ACCESSWIRE
05 May 2021, 00:31 GMT+10
NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the 'Company') (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ('Prasco'), has launched Elite's generic Loxapine capsules.
Elite entered a license, supply, and distribution agreement ('Agreement') with Prasco for Elite's Abbreviated New Drug Application (ANDA) for Loxapine Succinate capsules, 5 mg, 10 mg, 25 mg, and 50 mg ('Loxapine Capsules'). Loxapine is indicated for the treatment of schizophrenia and is currently listed on the FDA drug shortage list.
Prasco will be the exclusive U.S. distributor for Loxapine capsules, which will be marketed under Burel Pharmaceutical's label. Under the Agreement, Prasco will provide sales, marketing, and distribution for the product, and Elite will manufacture the product.

Ohio , United-states , Nasrat-hakim , Chris-arington , Exchange-commission , Lannett-company , Pharmaceuticals-inc , Glenmark-pharmaceuticals-inc , Elite-pharmaceuticals , Abbreviated-new-drug-application , Loxapine-succinate , Loxapine-capsules

Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer

Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer
NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced today that Marc Bregman, CPA, has been appointed as Chief Financial Officer (CFO), effective May 17, 2021. Mr. Bregman and will report to Elite's President and CEO, Nasrat Hakim.
Mr. Bregman has more than 27 years of financial and operational experience, including positions as Controller at Langan Engineering & Environmental Services and Controller at Chemtrade Logistics. He held corporate financial positions at Chemetall and National Starch & Chemical Company and was a supervisor and senior auditor at Ernst & Young. Mr. Bregman brings experience in financial accounting, financial planning & analysis, governance & compliance, financial auditing, Sarbanes-Oxley Act (SOX) compliance, and cost accounting.

Marc-bregman , Nasrat-hakim , National-starch-chemical-company , Lannett-company , Jersey-institute-of-technology , Exchange-commission , Ernst-young , Pharmaceuticals-inc , Martin-tuchman-school-of-management , Langan-engineering-environmental-services , Glenmark-pharmaceuticals-inc , William-paterson-college